ClinicalTrials.gg
Not yet recruitingNCT07760350Updated Aug 12, 2026

Assessing the Feasibility of the "Heart Care Pairs" Intervention

An interventional study of Dyadic lifestyle intervention for CVD risk reduction in Hypertension (HTN), sponsored by University of Alabama at Birmingham. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
85
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 44 studies in Hypertension by University of Alabama at Birmingham — 13 open to participants now, 16 under way, 1 of them phase 3. Hypertension · University of Alabama at Birmingham.

Planned enrollment
18th of 38
85 · median 71
Started
2026
with 6 others
No phase
29 of 44
11 open now
Primary completion
2027-05
later than 4 of 15 live
Registered
42nd of 44
by date

Among the 44 studies in Hypertension by University of Alabama at Birmingham, this one is the 18th largest by planned enrollment of the 38 interventional ones that give a count, is one of 7 that started in 2026, is one of 29 with no phase, reaches primary completion later than 4 of the 15 other live ones, and was the 42nd registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

Browse Hypertension studies →

Open to participants now

13 of the 44 studies in Hypertension by University of Alabama at Birmingham are open now, in 1 country. Recruiting first, the newest first:

7 more — sign in →

By country, each count listing its studies:

All 13 open studies →

Where they have run

Who these studies take

Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 44 studies in Hypertension by University of Alabama at Birmingham, or all of them as a file.
02

Study summary

The researchers will invite 30 patients in primary care who have high blood pressure to participate in this health program with a supportive partner of their choosing (these will be the "participant pairs"). Participant pairs will be invited to complete the Heart Care Pairs health program that will include up to six sessions each including 1) some education on a health habit like physical activity and heart healthy foods, 2) goal setting together, and 3) talk about healthy communication to support one another with heart healthy habits. The researchers will work with participants to address things that get in the way of coming for visits like offering transportation and offering telehealth visits. The researchers are seeing how this program works in real life so participants will be asked to complete as many sessions as they want to and can attend. The researchers will be interested in what participants think about the sessions, if they were satisfied with the visits, and if they would recommend the program to others in their community. The researchers will ask these questions in interviews with participants. The researchers will also ask up to 25 primary care workers about how they view the program as helpful to their work with patients with high blood pressure and whether they would refer more patients to the program in the future.

Read the detailed description

The overall objective of the present pilot behavioral trial is to assess the feasibility and acceptability of a dyadic CVD risk reduction intervention to be delivered by behavioral health consultants in primary care practices for patients with HTN. In a preliminary investigation prior to this pilot project, the research team has confirmed feasibility of recruitment of dyads from primary care settings, assessed health and social support needs, and interest in an intervention like Heart Care Pairs while making ongoing systematic adaptations to the intervention. The next phase of pilot work outlined in this proposal will assess if the intervention will work in primary care by assessing retention, treatment process, and acceptability.

Aim 1: To determine the feasibility and acceptability of the Heart Care Pairs intervention with N=30 dyads including patients with HTN attending primary care and their chosen supportive partner using a mixed methods single-arm pragmatic trial.

Hyp 1: Heart Care Pairs will be feasible based on dyads attending \<70% of intervention sessions, completion of follow-up assessments and interviews, and overall patient- and partner-reported satisfaction with the intervention.

Aim 2: To assess primary care workflow and PCP acceptability of making referrals to a dyadic behavioral health intervention.

Hyp 2: PCPs will agree that they referred patients to the Heart Care Pairs intervention and that the availability of the referral is helpful for their practice.

03

Conditions studied

  • Hypertension (HTN)

Browse trials for

Keywords

  • hypertension
  • primary care
  • integrated behavioral health
  • dyadic intervention
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with hypertension and/or taking blood pressure lowering medications
  • willing to invite a supportive partner to participate for the duration of the study including an enrollment and baseline measurement visit, up to 6 intervention visits, and a post-intervention measurement visit.

Exclusion criteria

Exclusion Criteria:

  • untreated serious mental illness or cognitive decline that would limit ability to provide
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
85 participants (estimated)

Study arms

  • Experimental
    Intervention

    Dyadic lifestyle intervention for CVD risk reduction "Heart Care Pairs"

    Behavioral: Dyadic lifestyle intervention for CVD risk reduction

Interventions

  • BehavioralDyadic lifestyle intervention for CVD risk reduction

    This is a 6-session behavioral intervention delivered in primary care. The 6 educational topics include: 1) DASH diet; 2) Physical activity; 3) Stress management; 4) Healthy sleep habits; 5) Substance cessation (optional); 6) Adherence to medications and lifestyle habits. All sessions will include collaborative goal setting. And each educational topic will be paired with a communication skill: 1) Seeing others' perspectives; 2) Minimize efforts to control; 3) Non-judgmental language; 4) Support movement towards change; 5) Addressing relapse; and 6) Empathetic responding and self-advocacy.

06

What researchers measure

Primary outcomes

  1. Completion of follow-up assessments

    Number of surveys and interviews completed

    Time frame: Immediately post-intervention

  2. Time to complete recruitment

    Time from posting recruitment materials to enrollment of 30 dyads

    Time frame: From study start to end of recruitment, an average of 6 months

  3. Responsiveness to change on survey measures

    Change scores between baseline assessment to follow-up assessment

    Time frame: Baseline to immediately post-intervention - approximately 12 weeks

  4. Attendance to intervention sessions

    Number of sessions attended compared to number of sessions missed

    Time frame: Baseline to immediately post-intervention - approximately 12 weeks

  5. Treatment Satisfaction Questionnaire

    Participant ratings of satisfaction with the HCPs intervention. 9-items, with responses on a scale from 1-7. Some items assess satisfaction (1=extremely dissatisfied to 7=extremely satisfied), confidence (1=not at all confident, 7=extremely confident, certainty (1=not at all certain, 7=extremely certain), how easy to use/do the intervention was (1=extremely difficult, 7=extremely easy). Mean scores will be calculated for min score=1 and max score of 7. Higher scores indicate greater satisfaction, and lower burden with the intervention.

    Time frame: Immediately post-intervention

Secondary outcomes

  1. Health-related quality of life (HRQoL)

    1-item self-rated health status (Bullinger, 1996; Dumas, et al, 2020)

    Time frame: Baseline and immediately post-intervention

  2. Perceived Stress Scale - 10

    10-item Perceived Stress Scale (PSS-10; Roberti, et al, 2006). Responses range from 0=Never to 4=Very often. Scores are summed for total perceived stress score ranging from 0-40 with higher scores meaning higher perceived stress.

    Time frame: Baseline and immediately post-intervention

  3. Smoking status

    1-item cigarette smoking status and number cigarettes per day

    Time frame: Baseline and immediately post-intervention

  4. Patient Health Questionnaire - 9

    PHQ-9 depression screen (Kroenke, et al, 2001). Respondents endorse symptoms of depression over the past 2 weeks on a scale from 0=not at all to 3=nearly everyday. Scores are summed for total scores ranging from 0 to 27 with higher scores indicating greater severity of depression symptoms.

    Time frame: Baseline and immediately post-intervention

  5. Generalized anxiety disorder (GAD)-7

    GAD-7 screen for anxiety symptoms (Spitzer, et al., 2006). Respondents endorse symptoms of anxiety over the past 2 weeks on a scale from 0=not at all to 3=nearly everyday. Scores are summed for total scores ranging from 0 to 21 with higher scores indicating greater severity of anxiety symptoms.

    Time frame: Baseline and immediately pot-intervention

  6. Body mass index

    Approximation of body size based on clinic measured height and weight

    Time frame: Baseline and immediately post-intervention

  7. Mediterranean Eating Pattern Assessment (MEPA)

    Brief assessment of heart healthy eating, self-report recall for past week,16 items. Items assess self-reported number of servings per type of food in the past week. Items are scored based on thresholds meeting a mediterranean diet eating pattern (e.g., greater than or equal to 2 servings of vegetables per day). Scores range from 0-16 with higher scores being more adherent to mediterranean diet pattern (more heart healthy diet).

    Time frame: Baseline and immediately post-intervention

  8. International physical activity questionnaire short form (IPAQ-SF)

    Self-reported walking, moderate physical activity, vigorous physical activity, and sedentary time, 7-items (Lee, et al, 2011). Total met minutes are calculated for each activity domain. Walking MET minutes = 3.3\*walking days\* walking minutes. Moderate MET minutes = 4.0\*moderate days\*moderate minutes. Vigorous MET minutes=8.0\*vigorous days\*vigorous minutes. Total MET minutes = Waling MET min+Moderate MET min+Vigorous MET min.

    Time frame: Baseline and immediately post-intervention

  9. Sleep time

    1-item total average sleep time (Lloyd-Jones, et al, 2022)

    Time frame: Baseline and immediately post-intervention

  10. Adherence self-report questionnaire (ASRQ)

    Self reported medication adherence to blood pressure medicines (Zeller, et al., 2008) 1-item with 1=take all BP medications at the same time every day (excellent adherence) to 6=Hardly take any BP medications (poor adherence).

    Time frame: Baseline and immediately post-intervention

  11. Treatment Self Regulation Questionnaire

    Measure of autonomy, self-report 19-tems (Levesque, et al, 2007). 19-items assessed using a Likert-type scale from 1=Not at all true to 7=Very true. Mean of scores will be calculated with higher score meaning greater autonomy over heart healthy behaviors (taking medications, healthy diet, exercise).

    Time frame: Baseline and immediately post-intervention

  12. Important other climate questionnaire

    Measure of autonomy support, self-report 6-items (Williams, 2006). Responses are on a Likert Scale. Mean scores will be calculated with higher scores indicating greater support from "important others" with efforts to lower blood pressure.

    Time frame: Baseline and immediately post-intervention

  13. Social Support for Diet and Exercise Behaviors

    Social support from family, friends, supportive other related to healthy diet and exercise behavior (Sallis, et al., 1987). Responses range from 0=Rarely to 3=very often. Each question will be asked for "Family," "Friends," and "Study Partner." Mean scores for each relationship type will be calculated with higher scores indicate greater support with health behavior.

    Time frame: Baseline and immediately post-intervention

  14. Medical Outcomes Study (MOS) Social Support Survey

    A total of 19-items self-report for measures of global social support and subscales for: emotional/informational, tangible, affectionate, and positive social interaction. Responses to items range from 1=none of the time to 5=all of the time. The mean items responses are taken for each subscale with higher scores meaning greater social support (Sherbourne \& Stewart, 1991)

    Time frame: Baseline and immediately post-intervention

07

Study locations

1 site
  • Department of Family & Community Medicine; University of Alabama at Birmingham
    Birmingham, Alabama 35205, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for May 2027, 6 months later.

Of 1,407 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 6 months is below that.

Counting every sponsor, half of 1,502 studies reached it within 23 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 24, 2026
First posted
Aug 12, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
May 1, 2027
CompletionEst.
Jun 30, 2027
Last update
Aug 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07760350
Responsible party
Kaylee Crockett (Assistant Professor, University of Alabama at Birmingham) — Principal investigator
First posted
Aug 12, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
May 1, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Aug 12, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion